Leerink Partnrs Has Positive Forecast for CLOV Q2 Earnings

Clover Health Investments, Corp. (NASDAQ:CLOV) – Investment analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for shares of Clover Health Investments in a research note issued to investors on Wednesday, November 6th. Leerink Partnrs analyst W. Mayo now expects that the company will earn $0.03 per share for the quarter, up from their prior estimate of $0.02. The consensus estimate for Clover Health Investments’ current full-year earnings is ($0.13) per share.

Separately, UBS Group began coverage on Clover Health Investments in a report on Monday, October 7th. They set a “neutral” rating and a $4.00 price target on the stock.

Clover Health Investments Stock Down 7.1 %

Shares of CLOV stock opened at $3.41 on Friday. Clover Health Investments has a twelve month low of $0.61 and a twelve month high of $4.71. The stock’s fifty day simple moving average is $3.47 and its 200 day simple moving average is $2.17. The firm has a market capitalization of $1.70 billion, a P/E ratio of -17.05 and a beta of 2.03.

Hedge Funds Weigh In On Clover Health Investments

A number of hedge funds have recently modified their holdings of CLOV. Forum Financial Management LP raised its position in shares of Clover Health Investments by 33.8% during the third quarter. Forum Financial Management LP now owns 16,077 shares of the company’s stock worth $45,000 after acquiring an additional 4,061 shares during the last quarter. Bleakley Financial Group LLC raised its position in shares of Clover Health Investments by 98.9% during the third quarter. Bleakley Financial Group LLC now owns 20,090 shares of the company’s stock worth $57,000 after acquiring an additional 9,988 shares during the last quarter. Concurrent Investment Advisors LLC bought a new position in shares of Clover Health Investments during the third quarter worth about $28,000. Sigma Planning Corp bought a new position in shares of Clover Health Investments during the third quarter worth about $29,000. Finally, SignalPoint Asset Management LLC raised its position in shares of Clover Health Investments by 8.1% during the third quarter. SignalPoint Asset Management LLC now owns 150,684 shares of the company’s stock worth $425,000 after acquiring an additional 11,318 shares during the last quarter. Institutional investors and hedge funds own 19.77% of the company’s stock.

About Clover Health Investments

Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.